A Study of the Complete Response Rate with a Combination of High Dose Cytarabine and Cladribine in Refractory and Relapsed Acute Leukemia
Introduction: Acute leukemia covers a broad spectrum of hematological clonal diseases originating from the malignant transformation of stem cells. Current chemotherapeutic methods result in an incomplete response to primary regimens in 30-40% of cases. Methods: 20 patients who had been diagnosed wit...
Main Authors: | Reza Safaei Nodehi, Behrouz Gharib, Ramazaali Sharifian, Amirhossein Emami, Majid Moghadaszadeh, Sara Sardashti |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2010-03-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/233 |
Similar Items
-
A Study of the Complete Response Rate with a Combination of High Dose Cytarabine and Cladribine in Refractory and Relapsed Acute Leukemia
by: Reza Safaei Nodehi, et al.
Published: (2010-01-01) -
Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience
by: SV Gritsaev, et al.
Published: (2016-01-01) -
Comparison of High-Dose Cytarabine, Mitoxantrone, and Pegaspargase (HAM-pegA) to High-Dose Cytarabine, Mitoxantrone, Cladribine, and Filgrastim (CLAG-M) as First-Line Salvage Cytotoxic Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
by: Ciera L. Patzke, et al.
Published: (2020-02-01) -
The mortality and response rate after FLANG regimen in patients with refractory/relapsed acute leukemia
by: Vali A Mehrzad, et al.
Published: (2012-01-01) -
Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re‐induction chemotherapy
by: Min Ruan, et al.
Published: (2021-02-01)